This text examines the clinical significance of the surge of recent progress in Parkinson's research. Researchers have recently succeeded in cloning receptors for dopamine and they have also made significant advances in understanding the molecular nature of the interaction between dopamine and mediation of its actions in the brain. In addition, the mechanisms of action of MPTP, a toxin producing Parkinsonism in humans and animals, has been further elucidated and is now largely understood. Progress in Parkinson's Disease ...
Read More
This text examines the clinical significance of the surge of recent progress in Parkinson's research. Researchers have recently succeeded in cloning receptors for dopamine and they have also made significant advances in understanding the molecular nature of the interaction between dopamine and mediation of its actions in the brain. In addition, the mechanisms of action of MPTP, a toxin producing Parkinsonism in humans and animals, has been further elucidated and is now largely understood. Progress in Parkinson's Disease Research 2 reports on all of these developments with the aim of accelerating future research efforts in the field.
Read Less
